Efficacy and Safety of Roflumilast Cream 0.3% in Subjects with Plaque Psoriasis: a Phase 3 Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is a multi-center, randomized, double-blind, vehicle-controlled phase III study to evaluate the efficacy, safety, and PK profile of roflumilast cream 0.3% in Chinese subjects ≥6 years of age with plaque psoriasis.
Epistemonikos ID: b0a12150742f6449a118854affbd65cf4c1db035
First added on: Nov 01, 2024